MiNK Therapeutics Regains Full Compliance with Nasdaq Listing Requirements
MiNK Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat ...
SINTX Technologies Sells Technology Assesment and Transfer Subsidiary to Focus on Medical Device Market
Strategic Transaction Enhances Financial Flexibility and Supports Growth in Healthcare InnovationsSalt Lake City, UT, Feb. 20, 2025 (GLOBE ...